ArticleJournal of hematology & oncology2017

Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor D-1-methyl-tryptophan.

Xiaolong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.